Literature DB >> 21264530

Aberrant microRNA expression in human cervical carcinomas.

Qunxian Rao1, Qingli Shen, Hui Zhou, Yongpai Peng, Jing Li, Zhongqiu Lin.   

Abstract

Because altered microRNAs (miRNAs) expression patterns have been observed in a variety of diseased tissues, miRNA expression was compared in human cervical cancer tissues relative to adjacent normal cervical tissues in the present study. Microarray chips with 924 probes were used to detect the expression of miRNAs in cervical cancer tissue and adjacent normal cervical tissue of 13 patients with cervical cancer (11 squamous cervical cancers, one cervical adenocarcinoma, and one cervical sarcoma), all of whom were infected with human papilloma virus (HPV) 16 and/or HPV18. Compared to the expression levels in normal cervical tissues, 18 miRNAs (1.9%) were significantly upregulated (increase of ≥2×), and 19 miRNAs (2.1%) were significantly downregulated (decrease of ≤0.5×) in cervical cancer tissues. miRNA expression was independent of lymph node involvement, vascular invasion, and pathological differentiation. Taken together, cervical cancer tissues have altered expression of miRNAs relative to adjacent normal tissues. Further studies are necessary to determine whether aberrant miRNA expression is related to the pathogenesis of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21264530     DOI: 10.1007/s12032-011-9830-2

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  27 in total

Review 1.  Implication of microRNAs in drug resistance for designing novel cancer therapy.

Authors:  Fazlul H Sarkar; Yiwei Li; Zhiwei Wang; Dejuan Kong; Shadan Ali
Journal:  Drug Resist Updat       Date:  2010-03-17       Impact factor: 18.500

Review 2.  Small RNAs: classification, biogenesis, and function.

Authors:  V Narry Kim
Journal:  Mol Cells       Date:  2005-02-28       Impact factor: 5.034

3.  SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells.

Authors:  Christopher S Sullivan; Adam T Grundhoff; Satvir Tevethia; James M Pipas; Don Ganem
Journal:  Nature       Date:  2005-06-02       Impact factor: 49.962

4.  c-Myc-regulated microRNAs modulate E2F1 expression.

Authors:  Kathryn A O'Donnell; Erik A Wentzel; Karen I Zeller; Chi V Dang; Joshua T Mendell
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells.

Authors:  I Martinez; A S Gardiner; K F Board; F A Monzon; R P Edwards; S A Khan
Journal:  Oncogene       Date:  2007-11-12       Impact factor: 9.867

6.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.

Authors:  Caiping Gao; Zhiyu Zhang; Wenzhong Liu; Shudong Xiao; Weiqi Gu; Hong Lu
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

8.  Polymorphisms involved in the miR-218-LAMB3 pathway and susceptibility of cervical cancer, a case-control study in Chinese women.

Authors:  Xiaoyi Zhou; Xiaojun Chen; Lingmin Hu; Suping Han; Fulin Qiang; Yuling Wu; Li Pan; Hongbing Shen; Ying Li; Zhibin Hu
Journal:  Gynecol Oncol       Date:  2010-02-16       Impact factor: 5.482

9.  miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro.

Authors:  Hailan Chen; Ruby Shalom-Feuerstein; Joan Riley; Shu-Dong Zhang; Paola Tucci; Massimiliano Agostini; Daniel Aberdam; Richard A Knight; Giuseppe Genchi; Pierluigi Nicotera; Gerry Melino; Mariuca Vasa-Nicotera
Journal:  Biochem Biophys Res Commun       Date:  2010-03-15       Impact factor: 3.575

10.  Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth.

Authors:  Xiaohong Wang; Shuang Tang; Shu-Yun Le; Robert Lu; Janet S Rader; Craig Meyers; Zhi-Ming Zheng
Journal:  PLoS One       Date:  2008-07-02       Impact factor: 3.240

View more
  45 in total

1.  microRNA-218 expression and its association with the clinicopathological characteristics of patients with cervical cancer.

Authors:  Bei-Bei Tang; Shui-Yi Liu; Y U Zhan; Li-Qing Wei; Xiao-Lu Mao; Jin Wang; L I Li; Zhong-Xin Lu
Journal:  Exp Ther Med       Date:  2015-04-28       Impact factor: 2.447

Review 2.  Regulation of cellular miRNA expression by human papillomaviruses.

Authors:  Zhi-Ming Zheng; Xiaohong Wang
Journal:  Biochim Biophys Acta       Date:  2011-05-17

3.  MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.

Authors:  Rui-Qing Peng; Hai-Ying Wan; Hai-Fang Li; Min Liu; Xin Li; Hua Tang
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

4.  Meta-analysis of microRNA expression profiling studies in human cervical cancer.

Authors:  Mei-Yi Li; Xiao-Xia Hu
Journal:  Med Oncol       Date:  2015-04-24       Impact factor: 3.064

5.  Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.

Authors:  Min Luo; Dongxiang Shen; Wei Wang; Jiang Xian
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

Review 6.  Dysregulation of microRNA expression in human cervical preneoplastic and neoplastic lesions.

Authors:  Ádám Galamb; Márta Benczik; Balázs Zinner; Eszter Vígh; Kornélia Baghy; Csaba Jeney; András Kiss; Gábor Lendvai; Gábor Sobel
Journal:  Pathol Oncol Res       Date:  2015-01-20       Impact factor: 3.201

7.  Novel insights into the mechanisms by which lncRNA HOTAIR regulates migration and invasion in HeLa cells.

Authors:  Peng Zheng; Yaoqin Wu; Ying Chen; Zhuo Chen; Tongcun Zhang
Journal:  Cell Cycle       Date:  2022-01-28       Impact factor: 4.534

Review 8.  Cervical cancer development, chemoresistance, and therapy: a snapshot of involvement of microRNA.

Authors:  Tandrima Mitra; Selvakumar Elangovan
Journal:  Mol Cell Biochem       Date:  2021-08-28       Impact factor: 3.396

9.  Lack of Conserved miRNA Deregulation in HPV-Induced Squamous Cell Carcinomas.

Authors:  Jaroslav Nunvar; Lucie Pagacova; Zuzana Vojtechova; Nayara Trevisan Doimo de Azevedo; Jana Smahelova; Martina Salakova; Ruth Tachezy
Journal:  Biomolecules       Date:  2021-05-20

10.  A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens.

Authors:  Bogumil Kaczkowski; Marya Morevati; Maria Rossing; Finn Cilius; Bodil Norrild
Journal:  Open Virol J       Date:  2012-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.